ConductScience.org, home

Paper29259986

Apoptotic Signaling Pathways in Glioblastoma and Therapeutic Implications.

Valdés-Rives SA and 4 others. Biomed Res Int, 2017. Cited by 87 papers, by iCite.

Cite this record

ConductScience Library. Apoptotic Signaling Pathways in Glioblastoma and Therapeutic Implications. Papers, record 29259986. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29259986

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Apoptotic Signaling Pathways in Glioblastoma and Therapeutic Implications.
PubMed
Journal
Biomed Res Int
PubMed
Year
2017
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
87
iCite
Relative citation ratio, by iCite
3.46
iCite
Revised in PubMed
2024-06-05
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Valdés-Rives SASilvia Anahihttps://orcid.org/0000-0002-2104-4884
2Casique-Aguirre DDianahttps://orcid.org/0000-0001-5580-2551
3Germán-Castelán LLilianahttps://orcid.org/0000-0001-6701-1917
4Velasco-Velázquez MAMarco Ahttps://orcid.org/0000-0001-9717-0265
5González-Arenas AAlieshahttps://orcid.org/0000-0002-9506-3180

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ApoptosisMajor topic
Cell MovementMajor topic
Cell ProliferationMajor topic
GlioblastomaMajor topic
Humans
Neoplasm Invasiveness
Signal Transduction

Source PubMed

Download CSV of topics

References107

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115184909Analysis of the activation status of Akt, NFkappaB, and Stat3 in human diffuse gliomas.Lab Invest2004https://conductscience.org/library/papers/15184909PubMed
224944883Tumor suppressive miRNA-34a suppresses cell proliferation and tumor growth of glioma stem cells by targeting Akt and Wnt signaling pathways.FEBS Open Bio2014https://conductscience.org/library/papers/24944883PubMed
311381677Expression of nuclear factor-kappa B, tumor necrosis factor receptor type 1, and c-Myc in human astrocytomas.Neurol Med Chir (Tokyo)2001https://conductscience.org/library/papers/11381677PubMed
424507955Cancer therapeutics: Targeting the apoptotic pathway.Crit Rev Oncol Hematol2014https://conductscience.org/library/papers/24507955PubMed
528212562Overexpression of miR-29a reduces the oncogenic properties of glioblastoma stem cells by downregulating Quaking gene isoform 6.Oncotarget2017https://conductscience.org/library/papers/28212562PubMed
610914698Temozolomide and treatment of malignant glioma.Clin Cancer Res2000https://conductscience.org/library/papers/10914698PubMed
721968049Antitumor effect of dehydroxymethylepoxyquinomicin, a small molecule inhibitor of nuclear factor-κB, on glioblastoma.Neuro Oncol2012https://conductscience.org/library/papers/21968049PubMed
820624968Arsenic antagonizes the Hedgehog pathway by preventing ciliary accumulation and reducing stability of the Gli2 transcriptional effector.Proc Natl Acad Sci U S A2010https://conductscience.org/library/papers/20624968PubMed
924607407Osteopontin-CD44 signaling in the glioma perivascular niche enhances cancer stem cell phenotypes and promotes aggressive tumor growth.Cell Stem Cell2014https://conductscience.org/library/papers/24607407PubMed
1023378584Multiple functions of BCL-2 family proteins.Cold Spring Harb Perspect Biol2013https://conductscience.org/library/papers/23378584PubMed
118261449Subcellular localization of the bcl-2 protein in malignant and normal lymphoid cells.Cancer Res1994https://conductscience.org/library/papers/8261449PubMed
1223603977NVP-BEZ235, a novel dual PI3K/mTOR inhibitor, enhances the radiosensitivity of human glioma stem cells in vitro.Acta Pharmacol Sin2013https://conductscience.org/library/papers/23603977PubMed
1321879257MicroRNA-125b-2 confers human glioblastoma stem cells resistance to temozolomide through the mitochondrial pathway of apoptosis.Int J Oncol2012https://conductscience.org/library/papers/21879257PubMed
1422236189Deregulated signaling pathways in glioblastoma multiforme: molecular mechanisms and therapeutic targets.Cancer Invest2012https://conductscience.org/library/papers/22236189PubMed
1524552816Distinctive effects of the cellular inhibitor of apoptosis protein c-IAP2 through stabilization by XIAP in glioblastoma multiforme cells.Cell Cycle2014https://conductscience.org/library/papers/24552816PubMed
1623533755Inhibition of NF- κ B by Dehydroxymethylepoxyquinomicin Suppresses Invasion and Synergistically Potentiates Temozolomide and γ -Radiation Cytotoxicity in Glioblastoma Cells.Chemother Res Pract2013https://conductscience.org/library/papers/23533755PubMed
1725051975The mTOR kinase inhibitors polarize glioma-activated microglia to express a M1 phenotype.J Neuroinflammation2014https://conductscience.org/library/papers/25051975PubMed
1827994508CRISPR-Cas9: from Genome Editing to Cancer Research.Int J Biol Sci2016https://conductscience.org/library/papers/27994508PubMed
1925706986Metabolic reprogramming in mutant IDH1 glioma cells.PLoS One2015https://conductscience.org/library/papers/25706986PubMed
2014634621The Bcl-2 family: roles in cell survival and oncogenesis.Oncogene2003https://conductscience.org/library/papers/14634621PubMed

See all 107 referencesDownload CSV of references

Cited by63

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 87 citations.

PMIDTitleJournalYearIn PapersSource
42794423Pulsed Electromagnetic Fields Enhance Resveratrol-Induced Apoptosis Through Modulation of Apoptotic Signaling in U87-MG Glioblastoma Cells.Int J Mol Sci2026https://conductscience.org/library/papers/42794423PubMed
42381706Pyroptosis as a novel therapeutic target in glioblastoma multiforme: Mechanisms, molecular insights, and therapeutic potential.Mol Ther Nucleic Acids2026https://conductscience.org/library/papers/42381706PubMed
42043033Advances in Targeted Toxin Therapy for Malignant Gliomas: A Narrative Review.Toxins (Basel)2026https://conductscience.org/library/papers/42043033PubMed
41979920SCD1 and SCD5 modulate PARP-dependent DNA repair via fatty acid desaturation in glioblastoma.Cell Rep2026https://conductscience.org/library/papers/41979920PubMed
41958080The GPCR Connection: Linking Alzheimer's Disease and Glioblastoma.J Cell Mol Med2026https://conductscience.org/library/papers/41958080PubMed
41828436Overcoming Chemoresistance in Glioblastoma: Mechanisms, Therapeutic Strategies, and Functional Precision Medicine.Int J Mol Sci2026https://conductscience.org/library/papers/41828436PubMed
41281928Drug resistance in glioblastoma: Challenges, mechanisms and therapeutic strategies (Review).Mol Clin Oncol2026https://conductscience.org/library/papers/41281928PubMed
41008904Targeting the Mitochondria in High-Grade Gliomas.Cancers (Basel)2025https://conductscience.org/library/papers/41008904PubMed
40822033Ferroptosis as a therapeutic target in glioblastoma: Mechanisms and emerging strategies.Mol Ther Nucleic Acids2025https://conductscience.org/library/papers/40822033PubMed
40518661Quantitative Proteomic Analysis Reveals Different Functional Subtypes among IDH-Wildtype Glioblastoma.J Proteome Res2025https://conductscience.org/library/papers/40518661PubMed
40293574Doxorubicin and NFL-TBS.40-63 peptide loaded gold nanoparticles as a multimodal therapy of glioblastoma.Discov Nano2025https://conductscience.org/library/papers/40293574PubMed
39827337Chitinase-3-like-1: a multifaceted player in neuroinflammation and degenerative pathologies with therapeutic implications.Mol Neurodegener2025https://conductscience.org/library/papers/39827337PubMed
39668701Beta-Caryophyllene Augments Radiotherapy Efficacy in GBM by Modulating Cell Apoptosis and DNA Damage Repair via PPARγ and NF-κB Pathways.Phytother Res2025https://conductscience.org/library/papers/39668701PubMed
39507759Curcumin as a novel therapeutic candidate for cancer: can this natural compound revolutionize cancer treatment?Front Oncol2024https://conductscience.org/library/papers/39507759PubMed
39503973Cell death in glioblastoma and the central nervous system.Cell Oncol (Dordr)2025https://conductscience.org/library/papers/39503973PubMed
39296804Synergism of d-limonene and temozolomide on migratory and apoptotic behaviors of human glioblastoma cell lines.Bioimpacts2024https://conductscience.org/library/papers/39296804PubMed
39045029Combining the constitutive TRAIL-secreting induced neural stem cell therapy with the novel anti-cancer drug TR-107 in glioblastoma.Mol Ther Oncol2024https://conductscience.org/library/papers/39045029PubMed
38698968Immunogenic cell death mediated TLR3/4-activated MSCs in U87 GBM cell line.Heliyon2024https://conductscience.org/library/papers/38698968PubMed
38686058A review on potential heterocycles for the treatment of glioblastoma targeting receptor tyrosine kinases.Oncol Res2024https://conductscience.org/library/papers/38686058PubMed
38607071A Novel Approach for Glioblastoma Treatment by Combining Apoptosis Inducers (TMZ, MTX, and Cytarabine) with E.V.A. (Eltanexor, Venetoclax, and A1210477) Inhibiting XPO1, Bcl-2, and Mcl-1.Cells2024https://conductscience.org/library/papers/38607071PubMed

See all 63 cited byDownload CSV of cited by

Genes79

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
APAF1317PubTator's text mininghttps://conductscience.org/library/genes/317NCBI Gene
BAK1578PubTator's text mininghttps://conductscience.org/library/genes/578NCBI Gene
BAX581PubTator's text mininghttps://conductscience.org/library/genes/581NCBI Gene
BCL2596PubTator's text mininghttps://conductscience.org/library/genes/596NCBI Gene
BCL2L1598PubTator's text mininghttps://conductscience.org/library/genes/598NCBI Gene
BCL2L1010017PubTator's text mininghttps://conductscience.org/library/genes/10017NCBI Gene
BCL2L1110018PubTator's text mininghttps://conductscience.org/library/genes/10018NCBI Gene
BCL2L2599PubTator's text mininghttps://conductscience.org/library/genes/599NCBI Gene
BID637PubTator's text mininghttps://conductscience.org/library/genes/637NCBI Gene
BIRC2329PubTator's text mininghttps://conductscience.org/library/genes/329NCBI Gene
BIRC3330PubTator's text mininghttps://conductscience.org/library/genes/330NCBI Gene
BIRC657448PubTator's text mininghttps://conductscience.org/library/genes/57448NCBI Gene
BIRC779444PubTator's text mininghttps://conductscience.org/library/genes/79444NCBI Gene
BIRC8112401PubTator's text mininghttps://conductscience.org/library/genes/112401NCBI Gene
BOK666PubTator's text mininghttps://conductscience.org/library/genes/666NCBI Gene
CASP3836PubTator's text mininghttps://conductscience.org/library/genes/836NCBI Gene
CASP6839PubTator's text mininghttps://conductscience.org/library/genes/839NCBI Gene
CASP7840PubTator's text mininghttps://conductscience.org/library/genes/840NCBI Gene
CASP8841PubTator's text mininghttps://conductscience.org/library/genes/841NCBI Gene

See all 79 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/29259986

GET https://conductscience.org/api/papers/v1/29259986/references?page=2